Skip to main content
Explore URMC
URMC / Research / Clinical Trials / Study Details

Aromatherapy for Integrated Cancer Care

Research Question:
Does aromatherapy provide symptom relief experienced during chemotherapy?

Basic Study Information

The purpose of this clinical trial is to determine the feasibility and effectiveness of aromatherapy in relief of commonly reported symptoms in cancer patients undergoing chemotherapy. Aromatherapy is a noninvasive, minimal risk intervention that could potentially alleviate the severity of treatment-related symptoms. This study will evaluate the ability of four aromatherapy scents (ginger, lavender, orange, jojoba) to reduce the severity of seven chemotherapy-induced symptoms (nausea, vomiting, pain, anxiety/distress, fatigue, sleep difficulties, and lack of appetite). As part of the study, the participants will be asked to use an aromatherapy inhaler, which resembles a lipstick container, during three chemotherapy cycles. The participants will use the aromatherapy inhaler for 7 consecutive days. The investigators will ask the participants questions regarding demographics, clinical information, current severity of symptoms, and current methods of symptom management. There is a non-intervention baseline cycle during which subjects rate the severity of the seven different symptoms from 0 to 10 for seven consecutive days during their first chemotherapy study cycle. The next two study cycles are intervention cycles using the randomized aromatherapy. The participants will rate the severity of seven different symptoms from 0 to 10 each day the aromatherapy inhaler during each of the three chemotherapy cycles (i.e., 7 consecutive days during each chemotherapy cycle). Additionally, participants will report if they felt the aromatherapy helped with certain symptoms and if he/she were able to reduce taking extra medications for their symptoms. At the end of the study, the participants will be asked about his/her satisfaction with the aromatherapy used during the study. All of these measurements will provide a better understanding of the effectiveness of aromatherapy for symptom management.

Location: University of Rochester Medical Center, Wilmot Canter Center
Study Reference #: 00071162

Lead Researcher (Principal Investigator)

Lead Researcher:  Julie Wolf

Study Contact Information

Study Coordinator: Madeline Forster
Phone: (585) 695-5533

Additional Study Details

Study Details:
Participants are provided with folders containing the necessary forms for each cycle, as well as pre-addressed, stamped envelopes to mail in the forms after completion. Participants can keep the aromatherapy inhaler at the end of the study and are reimbursed for their participation.

Reimbursement:  Yes

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search